Distributed generation and its impact on power grids and microgrids protection
The National Institute of Standards and Technology, NIST, is assigned by the US Department of Energy, DoE, to drive Smart Grid developments and harmonization efforts in the power industry. Distributed Generation has been identified as one of the important areas for the Smart Grid developments. Multiple generation sources, bi-directional power flow, power flow time co-ordination and management bring significant benefits and challenges for the existing and emerging power grids and microgrids. In particular, the effect of distributed generation on protection concepts and approaches needs to be understood, and accounted for. This paper describes distributed generation concepts, applications and scenarios. Benefits and challenges are discussed and analyzed on a number of real life examples. Special considerations are provided on ensuring security and dependability, as well as on protection parameterization and coordination.
Dispersed generation interconnection-utility perspective
Interconnection of generation to an electric distribution system, which is primarily designed to serve radial loads, must not compromise reliability and quality of supply to customers or safety of public and equipment. This paper presents criteria used by BC Hydro, the third largest utility in Canada, to determine the requirements for interconnecting a generating source to its distribution system. The presented criteria discuss tradeoff involved in specifying the grounding connection of interconnecting transformer or how the size of a distributed generator impacts protection upgrades within the utility system, out-of-step tripping duty on the feeder breaker, and requirement of transfer trip to avoid temporary overvoltages. These criteria are applied consistently and uniformly to minimize cost of interconnection engineering. They are based on sound engineering principles to ensure that interconnection upgrades specified are justifiable and defensible, if necessary, to the utility's regulator to ensure open access of the grid.
Immune dysfunction following infection with chicken anemia agent and infectious bursal disease virus. II. Alterations of in vitro lymphoproliferation and in vivo immune responses.
To determine the functional impact of alterations in lymphocyte concentrations and ratios following infection with chicken anemia agent (CAA) alone or in combination with infectious bursal disease virus (IBDV) on the immune system of young chickens, in vitro lymphoproliferation assays and in vivo responses to vaccination with several common viral agents were assessed at various time intervals post-inoculation (PI). Concanavalin A (Con A), phytohemagglutinin (PHA) and pokeweed mitogen (PWM) stimulation of splenic lymphocytes (SPL) collected from control birds could not be detected until 10-14 days PI. Infection with CAA was characterized by significantly higher PWM stimulation of SPL at 17 days PI and significantly lower PWM stimulation of peripheral blood lymphocytes (PBL) at 14 days PI, compared with uninfected controls. Concanavalin A and PWM stimulation of SPL was significantly increased in birds inoculated with IBDV alone. Lymphocytes harvested from birds inoculated simultaneously with CAA and IBDV had significantly lower responses. Effects on humoral and cell-mediated immunity following CAA and/or IBDV were determined by evaluating vaccination responses to Newcastle disease virus (NDV), fowl pox virus (FPV) and infectious laryngotracheitis virus (ILTV) during the acute phase of CAA infection (2 weeks PI). Vaccination of birds 2 weeks following CAA infection at 1 day of age resulted in decreased protection against NDV (85.7%) and ILTV (7.1%) challenge compared with protection rates in control birds (100% and 53.3% respectively). Infectious bursal disease virus infection was associated with decreased protection against NDV (60%) only. Concomitant infection at 1 day of age resulted in a greater reduction in NDV challenge protection (33.3%), slightly decreased FPV protection (87.5%), increased numbers of persistent FPV vaccination lesions and increased protection against ILTV challenge (71.4%). Vaccination of birds 2 weeks following CAA infection at 2 weeks of age resulted in slightly decreased NDV humoral antibody, development of persistent FPV vaccination lesions (17%) and increased immunity to ILTV challenge compared with control birds (83.3% vs. 66.7%). Chickens inoculated with IBDV alone displayed a more severe depression in NDV antibody titers and only a slight decrease in ILTV protection. Vaccination following concomitant infection at 2 weeks of age resulted in a higher percentage of FPV persistent vaccination lesions (39%) and greatly enhanced immunity to ILTV challenge (100%).